2024 Coding Clinic 2nd Quarter: COPD and Z79

2024 Coding Clinic 2nd Quarter: COPD and Z79

Chronic obstructive pulmonary disease, (COPD), is an overarching term for conditions which cause difficulty breathing, specifically from some type of impediment to air movement. The two main types are emphysema and chronic bronchitis. Both types can be present in the same patient. The most common etiology is tobacco exposure. It is a chronic, irreversible condition, although steps can be taken to prevent its progression.

Emphysema is characterized by small airway (i.e., bronchioles) and air sac (i.e., alveoli) losing their elasticity resulting in hyperinflation and impairment of exhalation. Air becomes trapped in the lungs, and gas exchange (i.e., oxygen and carbon dioxide) is compromised. Sometimes a portion of the lung becomes so thin-walled and distended that it forms what is called a pulmonary bleb or bulla, the distinction being size (1 cm is the cut-off). These cannot return to normal function and present the risk of rupture, causing a spontaneous pneumothorax.

Emphysema causes shortness of breath and deranged blood gases. It can be due to a genetic condition, although smoking is the most common precipitant. It can be further subdivided pathologically (hence J43 codes for panlobular or centrilobular, for instance), but providers often do not detail which of these subtypes is present.

Chronic bronchitis affects the airways, i.e., trachea, bronchi, and bronchioles. There is an increase in inflammation and mucus secretion in the lining of the airway which causes diminished airflow. It is manifested as a productive cough of more than 3 months in a 2-year period. The character of sputum in chronic bronchitis can vary between patients and vary over time in the same patient (e.g., simple, mucopurulent, mixed). A change in sputum production or color can indicate exacerbation or infection.

To round out the explanations, asthma is an obstructive pulmonary condition (and, even though it is chronic, it is not batched in “COPD”) which is often seen in children as well as adults. It results from bronchoconstriction and inflammation. The smooth muscle in the airways reacts to inflammatory mediators and causes bronchospasm. Asthma is often set off by a trigger, like an upper respiratory infection, exposure to pollutants, smoke, or fumes, or exercise. It is more rapidly reversible than a COPD exacerbation. Again, COPD and asthma can coexist in a patient.

The coding classification is already inaccurate in establishing an Excludes1 for chronic bronchitis (J41.-) and COPD. Chronic bronchitis is the specificity under the umbrella of COPD. The classification should allow for being able to use J44.0 or J44.1 to provide the specificity of status.

If a provider doesn’t know what type the patient has, they just state “COPD” in their documentation. That would result in use of J44.9, COPD, unspecified. The “unspecified” in the title isn’t REALLY for only for type, though, it is also for status. If there is an infection or exacerbation, then the “unspecified” term is eliminated and COPD with status (J44.0 or J44.1, or both) would be used.

2024 American Hospital Association Coding Clinic (CC) 2nd quarter is advising that only J44.89, Other specified chronic obstructive pulmonary disease, should be assigned for verbiage of “asthma in a patient with COPD,” unless the clinician specifies the type of asthma or that the asthma is exacerbated. The J44 category was expanded in October 2023, and J44.89 was added.

I don’t really get this. First of all, this does not constitute specification of the COPD. The patient has two different conditions, COPD and asthma. Think of a childhood asthmatic who ignores the doctor’s advice, smokes, and develops chronic bronchitis. They have 2 different concomitant diagnoses. It may not be easy or even possible to sort out what component of an exacerbation is from COPD and what is from the asthma.

Furthermore, CC says “unspecified” is not considered a type of asthma. I would assert that “moderate persistent asthma, uncomplicated,” isn’t a TYPE of asthma; “Cough-variant asthma” might be considered a type. The initialism, “COPD” isn’t “specified,” either. Emphysema or chronic bronchitis are specified types of COPD.

In my opinion, the correct way to handle obstructive pulmonary disease would be (Please note, this is NOT the advice of CC or indexing!):

For COPD:

  • A code indicating specific type of COPD, if known (e.g., emphysema or chronic bronchitis). Chronic bronchitis can also be subdivided into simple, mucopurulent, or mixed (as can emphysema be subcategorized, as noted above).
  • If the COPD is in the context of a lower respiratory infection or if there is acute exacerbation, an additional code would be used to indicate that status

If no specificity or status were given, J44.9, Chronic obstructive pulmonary disease, unspecified, would be utilized.

For chronic asthmatic bronchitis, or asthma with COPD, or COPD with asthma (with no specificity of the COPD)

  • J44.89, Other specified chronic obstructive pulmonary disease
  • If the COPD is in the context of a lower respiratory infection or if there is acute exacerbation, another code (J44.0 or J44.1, or both) would be used to indicate that status
  • A code to indicate the patient has asthma, too: [severity specific/ intermittent vs. persistent] asthma; either uncomplicated, with (acute) exacerbation, or with status asthmaticus. We always have to remember that “other specified” codes are a bucket for multiple different conditions. There is value to providing the asthma specificity.

I always advise, “As many codes as it takes” to detail a patient’s condition, and the combination of asthma and COPD is a good illustration.

Additionally, there is advice on Newly Prescribed Hypoglycemic Medication Intended for Long-Term Use on pages 26-27. The questioner wanted to know whether you should use Z79 code for the initiation of anti-diabetic hypoglycemic medication.

The question was a bit ambiguous to me. For example, was the coding being done in a facility where the patient was being evaluated for a possible stroke and the medication was being started for the new-onset diabetes or was it regarding coding at the rehab facility subsequently? It makes a difference to me.

Per the Coding Guidelines, if a medication is being administered for a brief period of time to treat an acute illness or injury, you don’t use a Z79, Long-term (current) use of medication code. If a patient is admitted in the hospital and wasn’t taking a medication prior to the encounter, I do not think it is appropriate to assign a Z79 code during that inpatient encounter for the newly prescribed medication, even if there is intention for the patient to remain on it long-term. I think they are conflating this with the guidance about G2211, the HCPCS add-on code to indicate an ongoing provider-patient relationship, which can be used even on the first visit. Antihypertensives, anticoagulation, steroids – if initiated during this inpatient admission, I don’t think Z79 is applicable…yet.

However, on the next visit, be it in the office, a readmission, or in the rehab facility, the Z79 code would be applicable. You are detailing “a patient’s continuous use of a prescribed drug for the long-term treatment of a condition or for prophylactic use.” The intent of the code is to register that the patient is taking a medication which could potentially have side effects or interactions. If they were just started on it today, that would not be a realistic concern.

Just to throw a little monkey wrench into this scenario, if a patient were in the hospital for a prolonged period of time, and they had a complication from that medication which was started during and administered throughout the hospitalization, and intended to be continued post-discharge, I WOULD use a Z79 code at discharge. It helps tell the story because your coding is trying to depict what happened with a patient during their hospital encounter.

As always, I recommend that you read the Coding Clinic for yourself. And remember, I am not a cooperating party, just an interested one!

Citation: AHA Coding Clinic, American Hospital Association, Volume 11, Number 2, Second Quarter, 2024, p. 3.

Facebook
Twitter
LinkedIn

Erica Remer, MD, FACEP, CCDS, ACPA-C

Erica Remer, MD, FACEP, CCDS, ACPA-C has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. As physician advisor for University Hospitals Health System in Cleveland, Ohio for four years, she trained 2,700 providers in ICD-10, closed hundreds of queries, fought numerous DRG clinical determination and medical necessity denials, and educated CDI specialists and healthcare providers with engaging, case-based presentations. She transitioned to independent consulting in July 2016. Dr. Remer is a member of the ICD10monitor editorial board and is the co-host on the popular Talk Ten Tuesdays weekly, live Internet radio broadcasts.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

Stop revenue leakage and boost hospital performance by mastering risk adjustment and HCCs. This essential webcast with expert Cheryl Ericson, RN, MS, CCDS, CDIP, will reveal how inaccurate patient acuity documentation leads to lost reimbursements through penalties from poor quality scores. Learn the critical differences between HCCs and traditional CCs/MCCs, adapt your CDI workflows, and ensure accurate payments in Medicare Advantage and value-based care models. Perfect for HIM leaders, coders, and CDI professionals.  Don’t miss this chance to protect your hospital’s revenue and reputation!

May 29, 2025
I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025
2025 Coding Clinic Webcast Series

2025 ICD-10-CM/PCS Coding Clinic Update Webcast Series

Uncover critical guidance. HIM coding expert, Kay Piper, RHIA, CDIP, CCS, provides an interactive review on important information in each of the AHA’s 2025 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 14, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24